Fine Particulate Matter (PM 2.5) Promoted the Invasion of Lung Cancer Cells via an ARNT2/PP2A/STAT3/MMP2 Pathway

Clicks: 495
ID: 112099
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 2 articles by views in journal of biomedical nanotechnology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Accumulating evidence indicates that fine particulate matter (PM2.5) exposure is associated with many cardiopulmonary diseases, particularly lung carcinoma. Nevertheless, the underlying biological mechanisms by which PM2.5 exposure initiates and aggravates lung carcinoma remain elusive. I …
Reference Key
z2018journalfine Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chen Z;Ji N;Wang Z;Wu C;Sun Z;Li Y;Hu F;Wang Z;Huang M;Zhang M;;
Journal journal of biomedical nanotechnology
Year 2018
DOI
DOI not found
URL
https://www.pubmed.gov/30305224/
Keywords
lung National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals humans pubmed abstract nih national institutes of health national library of medicine pmid:30305224 doi:10.1166/jbn.2018.2645 zhongqi chen ningfei ji mingshun zhang air pollutants aryl hydrocarbon receptor nuclear translocator basic helix-loop-helix transcription factors lung neoplasms* matrix metalloproteinase 2 particulate matter stat3 transcription factor signal transduction

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.